Pre-analytical variables in coagulation testing associated with diagnostic errors in hemostasis

Laboratory Medicine

Volumn 43, Issue 2, 2012, Pages 1-10

  Favaloro, Emmanuel J ^a   Dorothy, M ^b   Lippi, Giuseppe ^c  

^a WESTMEAD HOSPITAL   (Australia)

^b Esoterix Inc   (United States)

^c ACADEMIC HOSPITAL OF PARMA   (Italy)

Author keywords

Coagulation; Diagnostic errors; Extra analytical variables; Hemostasis; Pre analytical variables

Indexed keywords

BLOOD CLOTTING FACTOR 12; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; D DIMER; EDETIC ACID; FRESH FROZEN PLASMA; HEPARIN; PROTEIN C; PROTEIN S; PROTHROMBIN; VON WILLEBRAND FACTOR;

AGE; ARTICLE; BLOOD ANALYSIS; BLOOD CLOTTING TEST; CIRCADIAN RHYTHM; DIAGNOSTIC ERROR; ENZYME LINKED IMMUNOSORBENT ASSAY; ETHNICITY; HEALTH STATUS; HEMATOCRIT; HEMOLYSIS; HEMOSTASIS; HUMAN; HYPERLIPIDEMIA; INTERNATIONAL NORMALIZED RATIO; LABORATORY PERSONNEL; LABORATORY TEST; NONHUMAN; PHYSICAL ACTIVITY; PROTHROMBIN TIME; SEX DIFFERENCE; STORAGE; STRESS; THAWING; THROMBIN TIME;

EID: 84865863660     PISSN: 00075027     EISSN: 19437730     Source Type: Journal    
DOI: 10.1309/LM749BQETKYPYPVM     Document Type: Article

References (54)

1. Plebani M. Errors in clinical laboratories or errors in laboratory medicine? Clin Chem Lab Med. 2006;44:750-759.
2. Lippi G, Guidi GC. Risk management in the preanalytical phase of laboratory testing. Clin Chem Lab Med. 2007;45:720-727.
3. Lippi G, Guidi GC, Mattiuzzi C, et al. Preanalytical variability: The dark side of the moon in laboratory testing. Clin Chem Lab Med. 2006;44:358-365.
4. Favaloro EJ, Lippi G, Adcock DM. Preanalytical and postanalytical variables: The leading causes of diagnostic error in hemostasis? Semin Thromb Hemost. 2008;34:612-634.
5. Lippi G, Favaloro EJ, Franchini M, et al. Milestones and perspectives in coagulation and hemostasis. Semin Thromb Hemost. 2009;35:9-22.
6. Favaloro EJ, Lippi G. Coagulation update: What's new in hemostasis testing? Thromb Res. 2011;127(Suppl 2):S13-S16.
7. Favaloro EJ, McVicker W, Hamdam S, et al. Improving the harmonisation of the International Normalized Ratio (INR): Time to think outside the box? Clin Chem Lab Med. 2010;48:1079-1090.
8. Lippi G, Favaloro EJ. Activated partial thromboplastin time: New tricks for an old dogma. Semin Thromb Hemost. 2008;34:604-611.
9. Lippi G, Franchini M, Targher G, et al. Help me, Doctor! My D-dimer is raised. Ann Med. 2008;40:594-605.
10. Favaloro EJ. Laboratory testing in disseminated intravascular coagulation. Semin Thromb Hemost. 2010;36:458-467.
11. Coppola A, Tufano A, Cerbone AM, et al. Inherited thrombophilia: Implications for prevention and treatment of venous thromboembolism. Semin Thromb Hemost. 2009;35:683-694.
12. Mina A, Favaloro EJ, Mohammed S, et al. A laboratory evaluation into the short activated partial thromboplastin time. Blood Coagul Fibrinolysis. 2010;21:152-157.
13. Lippi G, Salvagno GL, Ippolito L, et al. Shortened activated partial thromboplastin time: Causes and management. Blood Coagul Fibrinolysis. 2010;21:459-463.
14. Lippi G, Franchini M, Favaloro EJ. Pharmacogenetics of vitamin K antagonists: Useful or hype? Clin Chem Lab Med. 2009;47:503-515.
15. Lippi G, Banfi G, Buttarello M, et al. Recommendations for detection and management of unsuitable samples in clinical laboratories. Clin Chem Lab Med. 2007;45:728-736.
16. CLSI. Collection, Transport, and Processing of Blood Specimens for Testing Plasma-Based Coagulation Assays and Molecular Hemostasis Assays: Approved Guideline. 5th ed. CLSI document H21-A5. Wayne, PA: Clinical and Laboratory Standards Institute; 2008.
17. Kiechle FL, Adcock DM, Calam RR, et al. So You're Going to Collect a Blood Specimen An Introduction to Phlebotomy. College of American Pathologists. 12th ed. Northfield, IL; 2007.
18. Adcock DM, Kressin DC, Marlar RA. Effect of 3.2% vs 3.8% sodium citrate concentration on routine coagulation testing. Am J Clin Pathol. 1997;107:105-110.
19. CLSI. Procedures for the Collection of Diagnostic Blood Specimens by Venipuncture. Approved Standard. 6th ed. CLSI document H3-A6. Wayne PA: Clinical and Laboratory Standards Institute; 2007.
20. Raijmakers MT, Menting CH, Vader HL, et al. Collection of blood specimens by venipuncture for plasma-based coagulation assays: Necessity of a discard tube. Am J Clin Pathol. 2010;133:331-335.
21. Favaloro EJ, Lippi G, Raijmakers MT, et al. Discard tubes are sometimes necessary when drawing samples for hemostasis. Am J Clin Pathol. 2010;134:851.
22. Adcock DM, Kressin DC, Marlar RA. Minimum specimen volume requirements for routine coagulation testing: Dependence on citrate concentration. Am J Clin Pathol. 1998;109:595-599.
23. Chuang J, Sadler MA, Witt DM. Impact of evacuated collection tube fill volume and mixing on routine coagulation testing using 2.5 mL (pediatric) tubes. Chest. 2004;126:1262-1266.
24. Sharp MK, Mohammad SF. Scaling of hemolysis in needles and catheters. Ann Biomed Eng. 1998;26:788-797.
25. Zürcher M, Sulzer I, Barizzi G, et al. Stability of coagulation assays performed in plasma from citrated whole blood transported at ambient temperature. Thromb Haemost. 2008;99:416-426.
26. Awad MA, Selim TE, Al-Sabbagh FA. Influence of storage time and temperature on international normalized ratio (INR) levels and plasma activities of vitamin K dependent clotting factors. Hematology. 2004;9:333-337.
27. van den Besselaar AM, Meeuwisse-Braun J, Jansen-Grüter R, et al. Monitoring heparin by the activated partial thromboplastin time-the effect of pre-analytical conditions. Thromb Haemost. 1987;57:226-231.
28. Adcock DA, Kressin DC, Marlar RA. The effect of time and temperature variables on routine coagulation tests. Blood Coagul Fibrinolysis. 1998;9:463-470.
29. O'Neill EM, Rowley J, Hansson-Wicher H, et al. Effect of 24-hour whole-blood storage on plasma clotting factors. Transfusion. 1999;39:488-491.
30. Pengo V, Tripodi A, Reber G, et al. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. Update of the guidelines for lupus anticoagulant detection. J Thromb Haemost. 2009;7:1737-1740.
31. Favaloro EJ, Lippi G, Franchini M. Contemporary platelet function testing. Clin Chem Lab Med. 2010;48:579-598.
32. Heil W, Grunewald R, Amend M, et al. Influence of time and temperature on coagulation analytes in stored plasma. Clin Chem Lab Med. 1998;36:459-462.
33. Refaai MA, van Cott EM, Lukoszyk M, et al. Loss of factor VIII and von Willebrand activities during cold storage of whole blood is reversed by rewarming. Lab Hematol. 2006;12:99-102.
34. Woodhams B, Girardot O, Blanco MJ, et al. Stability of coagulation proteins in frozen plasma. Blood Coagul Fibrinolysis. 2001;12:229-236.
35. Favaloro EJ, Bonar R, Duncan E, et al. Identification of factor inhibitors by diagnostic haemostasis laboratories: A large multi-centre evaluation. Thromb Haemost. 2006;96:73-78.
36. Favaloro EJ, Bonar R, Duncan E, et al. Mis-identification of factor inhibitors by diagnostic haemostasis laboratories: Recognition of pitfalls and elucidation of strategies. A follow up to a large multicentre evaluation. Pathology. 2007;39:504-511.
37. Lippi G, Salvagno GL, Adcock DM, et al. Right or wrong sample received for coagulation testing? Tentative algorithms for detection of an incorrect type of sample. Int J Lab Hematol. 2010;32(1 Pt 2):132-138.
38. Lippi G, Blanckaert N, Bonini P, et al. Haemolysis: An overview of the leading cause of unsuitable specimens in clinical laboratories. Clin Chem Lab Med. 2008;46:764-772.
39. Siegel JE, Swami VK, Glenn P, et al. Effect (or lack of it) of severe anemia on PT and aPTT results. Am J Clin Pathol. 1998;110:106-110.
40. Marlar RA, Potts RM, Marlar AA. Effect on routine and special coagulation testing values of citrate anticoagulant adjustment in patients with high hematocrit values. Am J Clin Pathol. 2006;126:400-405.
41. Favaloro EJ, McDonald D, Lippi G. Laboratory investigation of thrombophilia: The good, the bad, and the ugly. Semin Thromb Hemost. 2009;35:695-710.
42. Favaloro EJ, Mohammed S, Pati N, et al. A clinical audit of congenital thrombophilia investigation in tertiary practice. Pathology. 2011;43:266-272.
43. Montagnana M, Favaloro EJ, Franchini M, et al. The role of ethnicity, age and gender in venous thromboembolism. J Thromb Thrombolysis. 2010;29:489-496.
44. Banfi G, Del Fabbro M. Biological variation in tests of hemostasis. Semin Thromb Hemost. 2009;35:119-126.
45. Favaloro EJ. Toward a new paradigm for the identification and functional characterization of von Willebrand disease. Semin Thromb Hemost. 2009;35:60-75.
46. Favaloro EJ, Wong RC. Laboratory testing for the antiphospholipid syndrome: Making sense of antiphospholipid antibody assays. Clin Chem Lab Med. 2011;49:447-461.
47. Plebani M, Lippi G. To err is human. To misdiagnose might be deadly. Clin Biochem. 2010;43:1-3.
48. Lippi G. Governance of preanalytical variability: Travelling the right path to the bright side of the moon? Clin Chim Acta. 2009;404:32-36.
49. Lippi G, Chance JJ, Church S, et al. Preanalytical quality improvement: From dream to reality. Clin Chem Lab Med. 2011;49:1113-1126.
50. NCCLS. Continuous Quality Improvement: Integrating Five Key Quality Systems; Approved Guideline. 2nd ed. NCCLS document GP22-A2. Wayne, PA: NCCLS; 2004.
51. CLSI. Quality Management System: A Model for Laboratory Services; Approved Guideline. CLSI document GP26-A4. Wayne, PA: Clinical and Laboratory Standards Institute; 2011.
52. Favaloro EJ, Lippi G. Laboratory reporting of haemostasis assays: The final post-analytical opportunity to reduce errors of clinical diagnosis in hemostasis? Clin Chem Lab Med. 2010;48:309-321.
53. Favaloro EJ, Lippi G. Laboratory testing and/or monitoring of the new oral anticoagulants/antithrombotics: For and against? Clin Chem Lab Med. 2011;49:755-757.
54. Favaloro EJ, Lippi G, Koutts J. Laboratory testing of anticoagulants - the present and the future. Pathology. 2011;43:682-692.